Plainsboro, NJ, United States of America

Mircea C Popescu

This inventor holds 24 USPTO granted patents and 3 published patent applications, plus 5 CIPO patents, primarily in Liposomal Drug Delivery. Top assignees: The Liposome Company, Inc., Biomira USA Inc., Xeme Biopharma Inc.. Active years: 1986-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mircea C Popescu. Retrieved from https://idiyas.com/inventor/mircea-c-popescu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 24 

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.9

ph-index = 19

Forward Citations = 1,802(Granted Patents)


Location History:

  • Plansboro, NJ (US) (2001)
  • Plainsboro, NJ (US) (1986 - 2023)

Company Filing History:


Years Active: 1986-2023

Loading Chart...
Loading Chart...
Areas of Expertise:
Liposomal Adjuvants
Cancer Vaccine
Steroidal Liposomes
Biologically Active Compounds
Immunogenic Liposomes
Patient-Specific Vaccine
Vesicle Stability
Pharmacological Agents
Drug Delivery Systems
Lipid Matrix Carriers
Tumor-Associated Neoantigens
Affinity Associated Vaccine
24 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Mircea C Popescu in Cancer Treatment

Introduction

Mircea C Popescu, located in Plainsboro, NJ, is a prominent inventor with an impressive portfolio of 24 patents. His work primarily focuses on advancements in therapeutic cancer vaccines and novel drug delivery systems, showcasing his commitment to improving cancer treatment methodologies.

Latest Patents

One of Mircea's latest patents is a therapeutic cancer vaccine that encompasses tumor-associated neoantigens and immunostimulants in a delivery system. This innovative vaccine aims to treat cancer by inducing both humoral and cellular immune responses against malignant cells. It comprises a delivery system that incorporates at least one peptide representing a genetic mutation linked to malignancies, at least one immunostimulant, and at least one type of lipid molecule.

Another significant patent by Mircea involves the production of multilamellar coalescence vesicles (MLCVs) containing increased amounts of biologically active compounds. The method he developed includes hydrating a powdered lipid in an aqueous buffer above the phase transition temperature, creating multilamellar vesicles, and then reducing their size to form small or large unilamellar vesicles. This technique allows for the formation of MLCVs that contain greater quantities of biologically active compounds without the need for organic solvents or dehydration steps, significantly enhancing the efficiency of drug delivery.

Career Highlights

Mircea has made notable contributions to the field of pharmaceutical science through his work at various organizations. He has been associated with The Liposome Company, Inc. and Biomira USA Inc., where he developed and implemented innovative drug delivery systems that have had a lasting impact on cancer treatment strategies.

Collaborations

Throughout his career, Mircea has collaborated with distinguished professionals, including Alan L Weiner and Andrew S Janoff. These collaborations have further advanced the research and development of innovative therapies, contributing to the field's growth and evolution.

Conclusion

Mircea C Popescu's groundbreaking patents and contributions to cancer treatment highlight his role as a visionary inventor in the pharmaceutical landscape. With a focus on developing effective therapeutic vaccines and advanced drug delivery methods, his work continues to inspire further research and innovation in the fight against cancer.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…